Discover
CVKD
Cadrenal Therapeutics, Inc.
3.17
1 x 3.04
1 x 2.98
bid
ask
-
0.17
5.09%
1 @ 04:00 PM
3.13 -0.04 (1.26%)
| Ytd | -53.24% | |
| 1y | -72.84% |
2.91
day range
3.78
2.55
52 week range
14.64
| Open | 3.22 | Prev Close | 3.34 | Low | 2.91 | High | 3.78 | Mkt Cap | 9.76M |
| Vol | 467.57K | Avg Vol | 70.05K | EPS | -5.59 | P/E | N/A | Forward P/E | -3.02 |
| Beta | N/A | Short Ratio | 1.17 | Inst. Own | 4.75% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-21 | 50-d Avg | 4.69 | 200-d Avg | 8.05 | 1yr Est | 35.67 |
| Income Statement | |||
| Operating Expenses | 2.51M | ||
| Research and Development Expense | 771.51K | ||
| Selling, General and Administrative Expense | 1.74M | ||
| Operating Income | -2.51M | ||
| Net Income | -2.50M | ||
| Net Income Common Stock | -2.50M | ||
| Net Income Common Stock (USD) | -2.50M | ||
| Consolidated Income | -2.50M | ||
| Earnings per Basic Share | -1.04 | ||
| Earnings per Basic Share (USD) | -1.04 | ||
| Earnings per Diluted Share | -1.04 | ||
| Earning Before Interest & Taxes (EBIT) | -2.50M | ||
| Earning Before Interest & Taxes (USD) | -2.50M | ||
| Weighted Average Shares | 2.41M | ||
| Weighted Average Shares Diluted | 2.41M | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.31M | ||
| Cash and Equivalents (USD) | 2.31M | ||
| Current Assets | 2.86M | ||
| Property, Plant & Equipment Net | 4.62K | ||
| Total Assets | 2.86M | ||
| Current Liabilities | 1.06M | ||
| Total Liabilities | 1.06M | ||
| Accumulated Retained Earnings (Deficit) | -41.46M | ||
| Shareholders Equity | 1.80M | ||
| Shareholders Equity (USD) | 1.80M | ||
| Assets Non-Current | 6.79K | ||
| Trade and Non-Trade Payables | 824.81K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 555.00 | ||
| Net Cash Flow from Financing | 1.30M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.70M | ||
| Issuance (Purchase) of Equity Shares | 1.30M | ||
| Net Cash Flow from Operations | -3.00M | ||
| Share Based Compensation | 252.36K | ||